Pain Relief by Continuous Intra-Peritoneal Nebulization of Ropivacaine During Gynecological Laparoscopic Surgery

Carmel Medical Center1 site in 1 country40 target enrollmentFebruary 2007

ConditionsLaparoscopic Surgical Procedures

Interventionsropivacaine Aeroneb Pro Nezulizer, Aerogen, Ireland

Drugsropivacaine

Overview

Phase: Phase 3
Intervention: ropivacaine
Conditions: Laparoscopic Surgical Procedures
Sponsor: Carmel Medical Center
Enrollment: 40
Locations: 1
Primary Endpoint: VAS score
Status: Completed
Last Updated: 17 years ago

Overview Investigators Eligibility Criteria Arms & Interventions Outcomes Sites Similar Trials

Overview

Brief Summary

In our prospective, randomized, placebo controlled and double-blinded study we will study the efficacy of intraperitoneal ropivacaine nebulization on pain relief during gynecological laparoscopic surgery.

Registry

clinicaltrials.gov

Start Date

February 2007

End Date

October 2007

Last Updated

17 years ago

Study Type

Interventional

Study Design

Parallel

Sex

Female

Investigators

Sponsor

Carmel Medical Center

Eligibility Criteria

Inclusion Criteria

•Elective gynecologic laparoscopic surgery including unilateral or bilateral salpingo-oopherectomy or ovarian cystectomy.
•The patient is not participating in other medical study at present or in the last 30 days.
•The patient signed on an informed consent.
•Age 18 years and above.
•ASA (American Society of Anesthesiologists) physical status grade 1- 2.

Exclusion Criteria

•Allergy to Ropivacaine, other local anesthetics or other medications listed in the protocol.
•The patient is participating in other medical experiment at present or in the last 30 days.
•Acute Pelvic Inflammatory Disease.
•Coumadin or Aspirin treatment.
•ASA physical status grade 3-
•Age \< 18 years.
•Significant arrythmias
•Analgesic treatment for chronic pain